Kolexia
Dermeche Slimane Oncologie médicale
Dermeche Slimane
Oncologie médicale
Centre Paoli-Calmettes
Marseille, France
86 Activités
38 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Néphrocarcinome Adénocarcinome Tumeurs de la prostate Métastase tumorale Tumeurs de la vessie urinaire Sarcopénie Tumeurs du rein Hypertension artérielle

Collaborateurs

Voir plus
Gravis-Mescam Gwenaelle
Gravis-Mescam Gwenaelle
Centre Paoli-Calmettes, Marseille, France
Pignot Geraldine
Pignot Geraldine
Centre Paoli-Calmettes, Marseille, France
Walz Jochen
Walz Jochen
Centre Paoli-Calmettes, Marseille, France
Rybikowski Stanislas
Rybikowski Stanislas
Centre Paoli-Calmettes, Marseille, France

Industries

Voir plus
A+A
122 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
71 collaboration(s)
Dernière en 2023
IQVIA
55 collaboration(s)
Dernière en 2023
P\S\L Group Services
32 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
EDEN: Prospective Therapeutic De-escalation and miRNA-M371 Biomarker Evaluation Phase II Study for Stage IIa/IIb < 3 cm Seminomas
Essai Clinique (Centre Léon-Bérard)   24 janvier 2024
1555P Cell-free DNA analysis in patients with metastatic gastroesophageal adenocarcinoma: Preliminary results of the REGIRI - PRODIGE 58 ancillary study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
GETUG-StORM-01: A Randomized Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
Essai Clinique (Centre François-Baclesse)   31 juillet 2023
AXIPAP: Multicenter Phase II Study of Axitinib in First Line Treatment for Patients With Locally Advanced or Metastatic Papillary Renal Cell Carcinoma (PRCC)
Essai Clinique (Centre Léon-Bérard)   01 septembre 2022
Efficacy of hyperthermic-intra-vesical chemotherapy in patients with BCG-refractory nonmuscle-invasive bladder cancer.
2022 ASCO Annual Meeting I   02 juin 2022
Preoperative EUS evaluation of the response to neoadjuvant therapy for gastric and esophagogastric junction cancer is correlated with survival: A single retrospective study of 97 patients.
Endoscopic ultrasound   22 avril 2022
Correction to: Transhiatal esophagectomy as a treatment for locally advanced adenocarcinoma of the gastroesophageal junction: postoperative and oncologic results of a single-center cohort : THE for locally advanced GEJC.
World journal of surgical oncology   01 avril 2022
Transhiatal esophagectomy as a treatment for locally advanced adenocarcinoma of the gastroesophageal junction: postoperative and oncologic results of a single-center cohort THE for locally advanced GEJC.
World journal of surgical oncology   06 mars 2022
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
Cancers   05 novembre 2021